Literature DB >> 3834829

Determination of pipemidic acid in plasma by normal-phase high-pressure liquid chromatography.

H Ito, M Inoue, M Morikawa, M Tsuboi, K Oka.   

Abstract

An improved high-pressure liquid chromatography procedure for determining the concentration of pipemidic acid in human plasma was developed, which uses a normal-phase silica gel column and aqueous mobile solvent system similar to that used in reverse-phase chromatography. Precolumn derivatization of pipemidic acid was achieved by a methylation reaction with boron trifluoride in methanol after extraction from plasma with chloroform containing 4% ethanol. The percent recovery of pipemidic acid was 88.3 +/- 7.7, the variation of which became negligible when quinacrine was used as an internal standard for the determination. High-pressure liquid chromatography analysis was performed by conventional silica gel and mobile solvent mixtures containing 3% of 0.14% HClO4 solution, 19% methanol, and 78% chloroform. The UV detector was set at 265 nm. The detection limit of pipemidic acid methyl ester was as low as 10 ng of the injection amounts or 0.5 micrograms of the plasma per ml, with 0.01 absorbance units (full scale) and a signal-to-noise ratio of 3.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3834829      PMCID: PMC180217          DOI: 10.1128/AAC.28.2.192

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.

Authors:  G Y LESHER; E J FROELICH; M D GRUETT; J H BAILEY; R P BRUNDAGE
Journal:  J Med Pharm Chem       Date:  1962-09

2.  Pipemidic acid: absorption, distribution, and excretion.

Authors:  M Shimizu; S Nakamura; Y Takase; N Kurobe
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

3.  Simultaneous determination of lidocaine and its principal metabolites by liquid chromatography on silica gel, with aqueous eluent.

Authors:  K Kushida; K Oka; T Suganuma; T Ishizaki
Journal:  Clin Chem       Date:  1984-05       Impact factor: 8.327

4.  Pyrido(2,3-d)pyrimidine antibacterial agents. 3. 8-Alkyl- and 8-vinyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-carboxylic acids and their derivatives.

Authors:  J Matsumoto; S Minami
Journal:  J Med Chem       Date:  1975-01       Impact factor: 7.446

5.  Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.

Authors:  W H Traub
Journal:  Chemotherapy       Date:  1984       Impact factor: 2.544

6.  Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice.

Authors:  S Nakamura; K Nakata; H Katae; A Minami; S Kashimoto; J Yamagishi; Y Takase; M Shimizu
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.